Demonstration of cardiac involvement of sarcoidosis by contrast-enhanced multislice computed tomography and delayed-enhanced magnetic resonance imaging

Journal of Computer Assisted Tomography

Volumn 29, Issue 6, 2005, Pages 745-748

  Kanao, Shotaro ^a   Tadamura, Eiji ^a   Yamamuro, Masaki ^a   Kubo, Shigeto ^a   Kimura, Takeshi ^a   Kita, Toru ^a   Togashi, Kaori ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiac sarcoidosis; Computed tomography; Magnetic resonance imaging

Indexed keywords

COMPUTERIZED TOMOGRAPHY; HEART; MAGNETISM; RESONANCE;

CARDIAC SARCOIDOSIS; COMPUTED TOMOGRAPHY; CONTRAST-ENHANCED; LOCALISATION; MULTISLICE COMPUTED TOMOGRAPHY; TOMOGRAPHY IMAGING;

MAGNETIC RESONANCE IMAGING;

IODINE;

ADULT; AGED; ANAMNESIS; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SARCOIDOSIS; SIGNAL TRANSDUCTION;

EID: 28044469848     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rct.0000177519.25045.01     Document Type: Article

References (15)

1. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med. 1997;336:1224-1234.
2. Shammas RL, Movahed A. Sarcoidosis of the heart. Clin Cardiol. 1993;16:462-472.
3. Silverman KJ, Hutchins GM, Bulkley BH, et al. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1979;58:1204-1211.
4. Matsui Y, Iwai K, Tachibana T, et al. Clinico-pathological study on fatal myocardial sarcoidosis. Ann NY Acad Sci. 1976;278:455-469.
5. Perry A, Vuitch F. Causes of death in patients with sarcoidosis: a morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med. 1995;119:167-172.
6. Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol. 2001;88:1006-1010.
7. Serra JJ, Monte GU, Mello ES, et al. Cardiac sarcoidosis evaluated by delayed-enhanced magnetic resonance imaging. Circulation. 2003;107(Suppl):e188- e189.
8. Smedema JP, Snoep G, van Kroonenburgh MPG, et al. Evaluation of accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol. 2005;45:1683-1690.
9. Tadamura E, Yamamuro M, Kubo S, et al. Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol. 2005;185:110-115.
10. Mochizuki T, Murase K, Higashino H, et al. Demonstration of acute myocardial infarction by subsecond spiral computed tomography: early defect and delayed enhancement. Circulation. 1999;99:2058-2059.
11. Nikolaou K, Knez A, Sagmeister S, et al. Assessment of myocardial infarctions using multidetector-row computed tomography. J Comput Assist Tomogr. 2004;28:286-292.
12. Koyama Y, Matsuoka H, Mochizuki T, et al. Assessment of reperfused acute myocardial infarction with two-phase contrast-enhanced helical CT: prediction of left ventricular function and wall thickness. Radiology. 2005;235:804-811.
13. Koyama Y, Mochizuki T, Higaki J. Computed tomography assessment of myocardial perfusion, viability, and function. J Magn Reson Imaging. 2004;19:800-815.
14. Sekiguchi M, Yazaki Y, Isobe M, et al. Cardiac sarcoidosis: diagnostic, prognostic and therapeutic considerations. Cardiovasc Drugs Ther. 1996;10:495-510.
15. Bergout A, Russell FK. Sarcoid heart disease: clinical course and treatment. Int J Cardiol. 2003;97:173-182.